| Neurofilaments as biomarkers in neurological disorders M Khalil, CE Teunissen, M Otto, F Piehl, MP Sormani, T Gattringer, ... Nature Reviews Neurology 14 (10), 577-589, 2018 | 1797 | 2018 |
| Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis K Bjornevik, M Cortese, BC Healy, J Kuhle, MJ Mina, Y Leng, SJ Elledge, ... Science 375 (6578), 296-301, 2022 | 1778 | 2022 |
| Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis G Disanto, C Barro, P Benkert, Y Naegelin, S Schädelin, A Giardiello, ... Annals of neurology 81 (6), 857-870, 2017 | 1131 | 2017 |
| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 865 | 2019 |
| A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ... Neurology 73 (22), 1914-1922, 2009 | 808 | 2009 |
| Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa J Kuhle, C Barro, U Andreasson, T Derfuss, R Lindberg, Å Sandelius, ... Clinical Chemistry and Laboratory Medicine (CCLM) 54 (10), 1655-1661, 2016 | 755 | 2016 |
| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 686 | 2019 |
| Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis CH Lu, C Macdonald-Wallis, E Gray, N Pearce, A Petzold, N Norgren, ... Neurology 84 (22), 2247-2257, 2015 | 574 | 2015 |
| Increased neurofilament light chain blood levels in neurodegenerative neurological diseases J Gaiottino, N Norgren, R Dobson, J Topping, A Nissim, A Malaspina, ... PloS one 8 (9), e75091, 2013 | 524 | 2013 |
| Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis C Barro, P Benkert, G Disanto, C Tsagkas, M Amann, Y Naegelin, ... Brain 141 (8), 2382-2391, 2018 | 512 | 2018 |
| Blood neurofilament light chain as a biomarker of MS disease activity and treatment response J Kuhle, H Kropshofer, DA Haering, U Kundu, R Meinert, C Barro, ... Neurology 92 (10), e1007-e1015, 2019 | 510 | 2019 |
| Serum neurofilament light levels in normal aging and their association with morphologic brain changes M Khalil, L Pirpamer, E Hofer, MM Voortman, C Barro, D Leppert, ... Nature communications 11 (1), 812, 2020 | 507 | 2020 |
| Blood GFAP as an emerging biomarker in brain and spinal cord disorders A Abdelhak, M Foschi, S Abu-Rumeileh, JK Yue, L D’Anna, A Huss, ... Nature Reviews Neurology 18 (3), 158-172, 2022 | 485 | 2022 |
| Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases M Bacioglu, LF Maia, O Preische, J Schelle, A Apel, SA Kaeser, ... Neuron 91 (1), 56-66, 2016 | 467 | 2016 |
| Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ... The Lancet Neurology 21 (3), 246-257, 2022 | 407 | 2022 |
| Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ... Multiple Sclerosis Journal 21 (8), 1013-1024, 2015 | 403 | 2015 |
| FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis M Mehling, V Brinkmann, J Antel, A Bar-Or, N Goebels, C Vedrine, ... Neurology 71 (16), 1261-1267, 2008 | 402 | 2008 |
| Consensus guidelines for lumbar puncture in patients with neurological diseases S Engelborghs, E Niemantsverdriet, H Struyfs, K Blennow, R Brouns, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 8, 111-126, 2017 | 364 | 2017 |
| Lack of association between antimyelin antibodies and progression to multiple sclerosis J Kuhle, C Pohl, M Mehling, G Edan, MS Freedman, HP Hartung, ... New England Journal of Medicine 356 (4), 371-378, 2007 | 317 | 2007 |
| Neurofilament light chain: a biomarker for genetic frontotemporal dementia LH Meeter, EG Dopper, LC Jiskoot, R Sanchez‐Valle, C Graff, L Benussi, ... Annals of clinical and translational neurology 3 (8), 623-636, 2016 | 296 | 2016 |
